These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38343098)

  • 1. Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study.
    Lim MY; Rodgers GM; Branch DW; Simonsen SE
    Haemophilia; 2024 Mar; 30(2):470-477. PubMed ID: 38343098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study.
    Govorov I; Löfgren S; Chaireti R; Holmström M; Bremme K; Mints M
    PLoS One; 2016; 11(10):e0164683. PubMed ID: 27780267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postpartum Hemorrhage in Women with von Willebrand Disease: Consider Other Etiologies.
    Kazi S; Arusi I; McLeod A; Malinowski AK; Shehata N
    J Obstet Gynaecol Can; 2022 Sep; 44(9):972-977. PubMed ID: 35569789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
    Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
    J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis.
    James AH; Konkle BA; Kouides P; Ragni MV; Thames B; Gupta S; Sood S; Fletcher SK; Philipp CS
    Haemophilia; 2015 Jan; 21(1):81-7. PubMed ID: 25333737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey.
    Stoof SC; van Steenbergen HW; Zwagemaker A; Sanders YV; Cannegieter SC; Duvekot JJ; Leebeek FW; Peters M; Kruip MJ; Eikenboom J
    Haemophilia; 2015 Jul; 21(4):505-12. PubMed ID: 25688733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand Disease and other hereditary haemostatic factor deficiencies in women with a history of postpartum haemorrhage.
    Majluf-Cruz K; Anguiano-Robledo L; Calzada-Mendoza CC; Hernández-Juárez J; Moreno-Hernández M; Domínguez-Reyes VM; Figueroa-Torres AG; Gomez-Rosas P; Arreola-Diaz R; García-Lee MT; Ricardo-Moreno MT; Sosa-Camas RE; Garcia-Chavez J; Vela Ojeda J; Isordia-Salas I; Majluf-Cruz A
    Haemophilia; 2020 Jan; 26(1):97-105. PubMed ID: 31823446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
    Federici AB
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate.
    Iorio A; James P; Ma A; Srivastava A
    J Thromb Haemost; 2024 Oct; 22(10):2739-2744. PubMed ID: 38950781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion.
    Reynen E; James P
    Semin Thromb Hemost; 2016 Oct; 42(7):717-723. PubMed ID: 27648611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy and delivery in women with von Willebrand disease.
    Castaman G; James PD
    Eur J Haematol; 2019 Aug; 103(2):73-79. PubMed ID: 31107984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of current perioperative management with Haemate
    Hazendonk HCAM; Heijdra JM; de Jager NCB; Veerman HC; Boender J; van Moort I; Mathôt RAA; Meijer K; Laros-van Gorkom BAP; Eikenboom J; Fijnvandraat K; Leebeek FWG; Cnossen MH;
    Haemophilia; 2018 May; 24(3):460-470. PubMed ID: 29573506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.
    Machin N; Ragni MV
    Blood Adv; 2020 Jul; 4(14):3234-3238. PubMed ID: 32692849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining international practices in the management of pregnant women with von Willebrand disease.
    Lavin M; Sánchez Luceros A; Kouides P; Abdul-Kadir R; O'Donnell JS; Baker RI; Othman M; Haberichter SL;
    J Thromb Haemost; 2022 Jan; 20(1):82-91. PubMed ID: 34661341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
    Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():679-691. PubMed ID: 37204745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of the Von Willebrand disease PREVENT trial.
    Ragni MV; Machin N; James AH; Seaman CD; Malec LM; Kessler CM; Konkle BA; Kouides PA; Neff AT; Philipp CS; Brooks MM
    Thromb Res; 2017 Aug; 156():8-13. PubMed ID: 28577390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
    de Wee EM; Sanders YV; Mauser-Bunschoten EP; van der Bom JG; Degenaar-Dujardin ME; Eikenboom J; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Hamulyák K; Nijziel MR; Fijnvandraat K; Leebeek FW;
    Thromb Haemost; 2012 Oct; 108(4):683-92. PubMed ID: 22918553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease.
    Gill JC; Shapiro A; Valentino LA; Bernstein J; Friedman C; Nichols WL; Manco-Johnson M
    Haemophilia; 2011 Nov; 17(6):895-905. PubMed ID: 21535320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.